Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells

Summary

A single arm, single center trial to assess the safety and efficacy of restoring function in damaged optic nerves using autologous purified populations of bone-marrow derived stem cells (BM-SCs) through a 24 month follow up period.

Timeline

Start

2013-04

Primary completion

2021-09-01

Completion

2021-10-01

Drugs

Indications